Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm

Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

17 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7
Recruiting: 5
Ph III recruiting: 3
Growth YoY: —
Industry share: 0%
Top sponsor: ARCAGY/ GINECO GROUP
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05256225	Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma	recruiting	Phase 3	360	National Cancer Institute (NCI)NIH	3	Sep 29, 2026	clinicaltrials
NCT03651206	Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib(ROCSAN)	recruiting	Phase 2 / Phase 3	138	ARCAGY/ GINECO GROUPOTHER	3	Sep 9, 2026	clinicaltrials